Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

MAIT cell subtypes in multiple sclerosis

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Antibodies to Epstein-Barr virus and neurotropic viruses in multiple sclerosis and optic neuritis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. B cells from patients with multiple sclerosis have a pathogenic phenotype and increased LTα and TGFβ1 response

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Inflammatory markers of CHMP2B-mediated frontotemporal dementia

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Early Intrathecal T Helper 17.1 Cell Activity in Huntington Disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Disentangling white-matter damage from physiological fibre orientation dispersion in multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Intoxicationer og ernæringsdeficit

    Research output: Chapter in Book/Report/Conference proceedingBook chapterEducation

View graph of relations

In patients with multiple sclerosis (MS) and healthy controls (HC) we studied circulating MAIT cells and MAIT cell subtypes expressing CXCR3 and CCR6 by flow cytometry. Absolute numbers of MAIT cells and specifically Tc17-like MAIT cells were lower in patients with primary progressive MS (PPMS) than in controls. Low numbers of Tc17-like MAIT cells were associated with smoking and high concentrations of myelin basic protein in the cerebrospinal fluid. Treatment with alemtuzumab and dimethyl fumarate decreased MAIT cell frequencies. Altogether, we have identified specific MAIT cell subtypes related to PPMS, smoking and demyelination, and MAIT cell effects of MS therapies.

Original languageEnglish
JournalJournal of Neuroimmunology
Volume339
Pages (from-to)577117
ISSN0165-5728
DOIs
Publication statusPublished - 15 Feb 2020

ID: 59754035